Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-17 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-13 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-13 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-09 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-09 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-08 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |